DocMed Technology, a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, has signed a partnership agreement with SATA CommHealth, one of four Anchor Operators appointed by Singapore’s Ministry of Manpower under its Primary Care Plan, to deliver a new primary healthcare system for migrant workers starting on 1 April 2022.

Under the Partnership, DocMed’s WellAway e-pharmacy will provide e-pharmacy medication delivery to the migrant worker patient after a teleconsultation by SATA CommHealth. To ensure integrity of the medications, a team of professional pharmacists and pharmacy technicians supplies the medications in accordance with Singapore Standards.

DocMed is currently evaluating strategic investors for its business expansion needs. The investments will help fund the regional rollout of its various digital platforms and support their inhouse technology development capabilities, such as the use of artificial intelligence for healthcare data analytics.